“She lived life to the fullest and did so unapologetically. It didn’t matter that she had spinal muscular atrophy. It didn’t matter that she was a Black woman in a society that didn’t fight for her. She was still going to fight for the life she deserved.”
The edited cells are a step toward studying the degenerative neurological disorder in a primate model, which has proven elusive.
The predictive tool is a boon for researchers studying how cells control the activity of genes, helping explain how cells achieve their key functions and how they go haywire, as happens in diseases such as cancer.
Scientists in the University of Wisconsin–Madison Department of Biochemistry are blasting E. coli bacteria with ionizing radiation once a week to watch evolution happen in real time as the bacteria become radiation resistant.
Jason Peters and colleagues have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.
Mike Sussman, longtime director of the UW–Madison Biotechnology Center, has announced that he is stepping down from that position to serve as director of the genome center. Chris Bradfield has been named interim Biotechnology Center director.
Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.
A new study shows an improved tactic for delivering new genes into the eye's drain, called the trabecular meshwork, offering a promising treatment for glaucoma.
“Most young people with Friedreich’s ataxia develop severe heart problems and are wheelchair-bound," says researcher Aseem Ansari, "but the disease is so rare that few drug companies invest in it."